Protagonist Therapeutics Inc buy Barclays PLC
Start price
17.09.25
/
50%
€53.00
Target price
17.09.26
€60.73
Performance (%)
139.62%
Price
17:03
€127.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Protagonist Therapeutics Inc has seen massive gains of 139.62%. This prediction currently runs until 17.09.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 8.547% | 8.547% |
| iShares Core DAX® | 1.842% | 1.387% |
| iShares Nasdaq 100 | 4.659% | -1.797% |
| iShares Nikkei 225® | 3.963% | -5.216% |
| iShares S&P 500 | 3.700% | 1.576% |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€88.00
19.03.26
19.03.26
€103.58
19.03.27
19.03.27
44.32%
17:03
17:03
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€77.00
26.02.26
26.02.26
€95.61
26.02.27
26.02.27
64.94%
17:03
17:03
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
07.11.25
07.11.25
€76.27
07.11.26
07.11.26
84.06%
17:03
17:03